|
|
|
Mark co-founded Illumina in 1998 and served as Vice President of Genomics. His career includes serving as Director of Genetics Research at Affymetrix and CEO/CSO of Prognosys Biosciences before co-founding Encodia.
He holds a B.S. in Biochemistry from the University of New South Wales and a Ph.D. from the University of Cambridge. |
